TEVA which doesn’t want to be generic company exclusively ,will benefit of an existing branded drugs portfolio from Cephalon (20) as well as will integrate 20 to 30 drugs in phase 2/3 development stage.
This should provide additional TO to TEVA for the next few years.
Link to more detailed Cephalon pipeline presentation
Linksforpharma.com is a pharmaceutical industry dedicated portal.
Linksforpharma.com provides a selection of resources from the internet on the pharma sector.
Registered people at Linksforpharma may publish individual profile as well as company profile to built a sectorial community.
As a free service, linksforpharma.com creates and publishes presentations, illustrating news and development in the pharma field.
Presentations from linksforpharma (of which this one), have been made thanks to internet publicly available information, such as: articles, blog posts, press releases, yahoo finance, google news, etc…